Intratemporal Tumors of the Facial Nerve Workup

  • Author: Jacek Szudek, MD, PhD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Apr 13, 2012
 

Laboratory Studies

  • Because the diagnosis of Bell palsy is one of exclusion, the astute otolaryngologist must rule out other causes of acute progressive facial nerve paralysis. Bell palsy does typically not present with hearing loss; the absence of hearing thus should alert the clinician to further investigate the possibility of a facial nerve tumor.
  • A detailed head and neck examination should be performed, with focus on certain physical examination findings.
  • Evaluation of facial nerve status
    • Have the patient repeat facial movements; assess for subtle asymmetry.
    • Observe for involuntary facial twitching.
    • Evaluate the eyelids: Ask the patient to close the eye; attempt to lift up the eyelid with your finger. Note any asymmetry between sides.
    • Evaluate for scleral show and corneal dryness. Referral to an ophthalmologist may be necessary.
    • Consider photographs.
    • Use an objective classification scheme, such as the House-Brackmann scale, to document the extent of facial weakness or paralysis.
  • Evaluation of the external, middle, and inner ear
    • Perform pneumatic otoscopy; observe for a possible mass.
    • Tuning fork examinations should be performed. The presence of conductive or sensorineural hearing loss should be documented.
    • Consider obtaining an audiogram, especially if the history or physical findings include hearing loss.
  • Evaluation of the neck
    • Pay particular attention to the parotid region. A mass may be present.
    • A thorough neck examination for adenopathy should also be performed.
Next

Imaging Studies

  • CT scanning
    • High-resolution, thin-cut CT imaging of the temporal bone is believed to be superior to MRI for visualization of bony structures.
    • High-resolution CT imaging of the temporal bone with axial and coronal views can aid in localization of tumor margins and involvement or erosion of adjacent structures.
    • A tumor along the course of the intratemporal facial nerve does not have to be very large to be symptomatic. Additionally, nonspecific enhancement of the nerve is commonly observed. Therefore, by defining the bony anatomy, CT scanning can add confirmatory or exclusionary evidence of the presence of these tumors.
    • Bony spicules within hemangiomas are also sometimes noted, which may be helpful in differentiating these lesions from schwannomas.
  • Gadolinium-enhanced MRI of the posterior fossa and temporal bones
    • MRI is the criterion standard for assessing soft tissue, such as the facial nerve. It provides specific information regarding perineural invasion and soft tissue involvement.
    • Facial nerve neuromas can arise from any facial nerve segment. Therefore, all facial nerve segments should be imaged and studied in detail.
    • This study is helpful in determining whether a larger size tumor is present. Obtaining MRI is not necessary in every case of Bell palsy because MRI results do not change the initial management. However, if a tumor is suspected, perform MRI. Note that tumors of the intratemporal facial nerve might escape MRI visualization because of their size. The most common histopathologic types (schwannoma and hemangioma) appear as enhancing lesions on T1-weighted images.
    • Radiographically distinguishing between an intracanalicular seventh nerve tumor and vestibular schwannomas is often impossible. Frequently, this rare diagnosis is made intraoperatively.
Previous
Next

Other Tests

  • Audiologic testing and immittance measures
    • A pure tone audiogram should be obtained.
    • Stapedial reflexes should be performed, although they are not always reliable indicators of distal facial nerve function.
  • Electroneuronography
    • Surgical intervention for facial nerve tumors is initiated once a patient's facial nerve function has deteriorated to the point at which the expected result would be nearly equivalent to the patient's current function (ie, House-Brackmann grade III or IV).
    • Because of this, serial electroneuronography (ENog) evaluations are helpful as a quantitative measure to augment the patient's self-assessment and the physician's observations.
  • Facial nerve action potential
    • Facial nerve action potential (FNAP) is a valid method for assessing facial nerve function waveform.
    • Facial nerve schwannomas are extremely slow growing and frequently present without facial dysfunction.
  • Photography
    • Photography of resting and dynamic facial nerve function also augments the physician's serial assessment of the deteriorating facial nerve.
    • Postoperative comparison is also made possible.
Previous
Next

Histologic Findings

The 2 most common tumors found along the course of the intratemporal facial nerve are schwannomas and hemangiomas. Schwannomas are well-circumscribed, encapsulated masses that arise from Schwann cells. They tend to splay rather than to invade the nerve fibers. Surgical removal of these tumors while sparing the nerve is possible, with better results in terms of postoperative function. They are firm gray masses that may have areas of cystic and xanthomatous change. They are characterized by bland palisading cells with slender nuclei.

The 2 classic conformations are the Antoni A and Antoni B patterns. The Antoni A pattern demonstrates elongated cells with cytoplasmic processes arranged in fascicles in areas of moderate to high cellularity with little stromal matrix; the nuclear-free zones of processes that lie between the regions of nuclear palisading are termed Verocay bodies. In the Antoni B pattern, the tumor is less cellular with a loose meshwork of cells along with microcysts and myxoid changes. Because the tumor displaces the nerve of origin as it grows, silver stains or immunostains for neurofilament proteins reveal axons that are largely excluded from the tumor. These tumors are immunoreactive to S-100. Malignant change is extremely rare, although local recurrence can occur with incomplete resection.

Hemangiomas are highly vascular lesions that consist of endothelium-lined channels. These tumors are lobulated but unencapsulated aggregates of closely packed, thin-walled capillaries, usually blood filled, and separated by scant connective tissue stroma. The lumina may be partially or completely thrombosed and organized. Rupture of vessels causes scarring and leads to the occasional hemosiderin pigment. Because of the proclivity of hemangiomas to be found near the geniculate ganglion, neuronal cell bodies and bone fragments often accompany the histologic specimen.

Of note, a histological specimen from the mastoid segment that demonstrates fibroadipose tissue without nerve tissue indicates a facial nerve pseudocyst, which is treated with surgical excision.

Previous
 
 
Contributor Information and Disclosures
Author

Jacek Szudek, MD, PhD  Resident Physician, Department of Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton

Jacek Szudek, MD, PhD, is a member of the following medical societies: Canadian Medical Protective Association, College of Physicians and Surgeons of Alberta, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Coauthor(s)

Arjun S Joshi, MD  Assistant Professor of Surgery, Division of Otolaryngology–Head and Neck Surgery, George Washington University School of Medicine and Health Sciences

Arjun S Joshi, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, and American Thyroid Association

Disclosure: Nothing to disclose.

Nader Sadeghi, MD, FRCSC  Professor, Otolaryngology-Head and Neck Surgery, Director of Head and Neck Surgery, George Washington University School of Medicine and Health Sciences

Nader Sadeghi, MD, FRCSC is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, American Thyroid Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Alan A Z Alexander, MD, MS  George Washington University School of Medicine

Alan A Z Alexander, MD, MS is a member of the following medical societies: American Medical Association, American Medical Student Association/Foundation, and American Psychiatric Association

Disclosure: Nothing to disclose.

K Paul Boyev, MD  Director of Hearing and Balance Center, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of South Florida

K Paul Boyev, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery and American Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael E Hoffer, MD  Director, Spatial Orientation Center, Department of Otolaryngology, Naval Medical Center of San Diego

Michael E Hoffer, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: American biloogical group Royalty Other

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Gerard J Gianoli, MD  Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Medvoy Ownership interest Management position; Cerescan Imaging Consulting; Headwatersmb Consulting fee Consulting; Venturequest Royalty Consulting

References
  1. Gross BC, Carlson ML, Moore EJ, Driscoll CL, Olsen KD. The intraparotid facial nerve schwannoma: a diagnostic and management conundrum. Am J Otolaryngol. Dec 19 2011;[Medline].

  2. Warren HG, Prevatt AA, Daly KA, Antonelli PJ. Cellular telephone use and risk of intratemporal facial nerve tumor. Laryngoscope. Apr 2003;113(4):663-7. [Medline].

  3. Edizer DT, Hajizade Y, Karaman E, Cansiz H. Intraparotid facial nerve neurofibroma in neurofibromatosis type 1. J Craniofac Surg. May 2011;22(3):1118-9. [Medline].

  4. Kim J, Moon IS, Lee JD, Shim DB, Lee WS. Useful surgical techniques for facial nerve preservation in tumorous intra-temporal lesions. Auris Nasus Larynx. Feb 2010;37(1):33-41. [Medline].

  5. Axon PR, Ramsden RT. Facial nerve action potentials: a study to assess waveform reliability. Am J Otol. Nov 2000;21(6):842-6. [Medline].

  6. Chung JW, Ahn JH, Kim JH, Nam SY, Kim CJ, Lee KS. Facial nerve schwannomas: different manifestations and outcomes. Surg Neurol. Sep 2004;62(3):245-52; discussion 452. [Medline].

  7. DeLozier HL, Spinella MJ, Johnson GD. Facial nerve paralysis with benign parotid masses. Ann Otol Rhinol Laryngol. Aug 1989;98(8 Pt 1):644-7. [Medline].

  8. Donzelli R, Maiuri F, Peca C, Cavallo LM, Motta G, de Divitiis E. Microsurgical repair of the facial nerve. Zentralbl Neurochir. May 2005;66(2):63-9. [Medline].

  9. Donzelli R, Motta G, Cavallo LM, Maiuri F, De Divitiis E. One-stage removal of residual intracanalicular acoustic neuroma and hemihypoglossal-intratemporal facial nerve anastomosis: technical note. Neurosurgery. Dec 2003;53(6):1444-7; discussion 1447-8. [Medline].

  10. Escada P, Capucho C, Silva JM, Ruah CB, Vital JP, Penha RS. Cavernous haemangioma of the facial nerve. J Laryngol Otol. Sep 1997;111(9):858-61. [Medline].

  11. Falcioni M, Russo A, Taibah A, Sanna M. Facial nerve tumors. Otol Neurotol. Nov 2003;24(6):942-7. [Medline].

  12. Frosch MP, Anthony DC, De Girolami U. The Central Nervous System. In: Kumar V, ed. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia, Pa: WB Saunders; 2004:1401-20.

  13. Isaacson B, Telian SA, McKeever PE, Arts HA. Hemangiomas of the geniculate ganglion. Otol Neurotol. Jul 2005;26(4):796-802. [Medline].

  14. Jabor MA, Amedee RG, Gianoli GJ. Primary meningioma of the fallopian canal. South Med J. Jul 2000;93(7):717-20. [Medline].

  15. Kertesz TR, Shelton C, Wiggins RH, Salzman KL, Glastonbury CM, Harnsberger R. Intratemporal facial nerve neuroma: anatomical location and radiological features. Laryngoscope. Jul 2001;111(7):1250-6. [Medline].

  16. Kim CS, Chang SO, Oh SH, Ahn SH, Hwang CH, Lee HJ. Management of intratemporal facial nerve schwannoma. Otol Neurotol. Mar 2003;24(2):312-6. [Medline].

  17. Kirazli T, Oner K, Bilgen C, Ovül I, Midilli R. Facial nerve neuroma: clinical, diagnostic, and surgical features. Skull Base. May 2004;14(2):115-20. [Medline].

  18. Linskey ME, Johnstone PA, O'Leary M, Goetsch S. Radiation exposure of normal temporal bone structures during stereotactically guided gamma knife surgery for vestibular schwannomas. J Neurosurg. Apr 2003;98(4):800-6. [Medline].

  19. Liu R, Fagan P. Facial nerve schwannoma: surgical excision versus conservative management. Ann Otol Rhinol Laryngol. Nov 2001;110(11):1025-9. [Medline].

  20. Marzo SJ, Zender CA, Leonetti JP. Facial nerve schwannoma. Curr Opin Otolaryngol Head Neck Surg. Jun 24 2009;[Medline].

  21. May M, Schaitkin BM. Tumors involving the facial nerve. In: The Facial Nerve. 2nd ed. New York, NY: Thieme Medical Publishers; 2000:393-408.

  22. McMenomey SO, Glasscock ME 3rd, Minor LB, Jackson CG, Strasnick B. Facial nerve neuromas presenting as acoustic tumors. Am J Otol. May 1994;15(3):307-12. [Medline].

  23. McMonagle B, Al-Sanosi A, Croxson G, Fagan P. Facial schwannoma: results of a large case series and review. J Laryngol Otol. Nov 2008;122(11):1139-50. [Medline].

  24. Minovi A, Vosschulte R, Hofmann E, Draf W, Bockmuhl U. Facial nerve neuroma: surgical concept and functional results. Skull Base. Nov 2004;14(4):195-200; discussion 200-1. [Medline].

  25. O'Donoghue GM. Tumors of the Facial Nerve. In: Jackler RK, ed. Neurotology. ed. St Louis, Mo: Mosby; 1994:1321-31.

  26. Perez R, Chen JM, Nedzelski JM. Intratemporal facial nerve schwannoma: a management dilemma. Otol Neurotol. Jan 2005;26(1):121-6. [Medline].

  27. Perez R, Chen JM, Nedzelski JM. Intratemporal facial nerve schwannoma: a management dilemma. Otol Neurotol. Jan 2005;26(1):121-6. [Medline].

  28. Pertzborn SL, Reith JD, Mancuso AA, Antonelli PJ. Epineurial pseudocysts of the intratemporal facial nerve. Otol Neurotol. May 2003;24(3):490-3. [Medline].

  29. Schoen FJ. Blood Vessels. In: Kumar V, ed. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia, Pa: WB Saunders; 2004:545-51.

  30. Selesnick SH, Burt BM. Regional spread of nonneurogenic tumors to the skull base via the facial nerve. Otol Neurotol. Mar 2003;24(2):326-33. [Medline].

  31. Shelton, Clough. Facial nerve tumors. In: Brackmann, Shelton, Arriaga, eds. Otologic Surgery. Philadelphia, Pa: WB Saunders; 1994:413-24.

  32. Shirazi MA, Leonetti JP, Marzo SJ, Anderson DE. Surgical management of facial neuromas: lessons learned. Otol Neurotol. Oct 2007;28(7):958-63. [Medline].

  33. Ussmüller J, Sanchez-Hanke M. [Histopathological studies of intratemporal growth behavior of middle ear carcinoma]. Laryngorhinootologie. Jan 2000;79(1):21-5. [Medline].

  34. von Doersten PG, Jackson CG, Manolidis S, Pappas D Jr, Glasscock ME 3rd. Facial nerve outcome in lateral skull base surgery for benign lesions. Laryngoscope. Oct 1998;108(10):1480-4. [Medline].

Previous
Next
 
A small acoustic neuroma within the internal auditory canal is easily observed on postgadolinium MRI.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.